• Q2 EPS Estimate for TScan Therapeutics Lowered by Analyst

    来源: Buzz FX / 10 3月 2025 01:56:16   America/New_York


    Q2 EPS Estimate for TScan Therapeutics Lowered by Analyst Written by MarketBeat March 10, 2025 Share Link copied to clipboard. Remove Ads TScan Therapeutics, Inc. ( NASDAQ:TCRX - Free Report ) - Investment analysts at HC Wainwright dropped
    Read more...
分享